Article
Public, Environmental & Occupational Health
Xingxia Zhang, Xinrong Chen, Jie Yang, Liang Du, Yong Zhou, Ka Li
Summary: This study summarizes the relationship between alcohol consumption and venous thromboembolism (VTE). The results show that low to moderate alcohol consumption is associated with a lower risk of VTE, but caution is needed when giving personal drinking advice due to the potential harm of alcohol.
JOURNAL OF PUBLIC HEALTH
(2022)
Review
Medicine, General & Internal
Xiaoyu Gao, Liangnan Zeng, Haorun Wang, Shan Zeng, Junjie Tian, Ligang Chen, Tangming Peng
Summary: This study pooled the prevalence of venous thromboembolism (VTE) in intensive care patients worldwide and identified several risk factors. The results showed a high prevalence of VTE in critically ill patients, emphasizing the need for attention to high-risk populations.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Rheumatology
Mark Yates, Amanda Mootoo, Maryam Adas, Katie Bechman, Sanketh Rampes, Vishit Patel, Sumera Qureshi, Andrew P. Cope, Sam Norton, James B. Galloway
Summary: A meta-analysis of RCT data on JAK inhibitors in IMID patients found a low risk of VTE, not supporting current warnings. These findings will help in the continued development of clinical guidelines for the use of JAK inhibitors in IMIDs.
ARTHRITIS & RHEUMATOLOGY
(2021)
Article
Hematology
James G. Payne, Vicky Tagalakis, Cynthia Wu, Alejandro Lazo-Langner
Summary: This study conducted a meta-analysis of three epidemiological studies in Canada to estimate the national VTE incidence rate. The results showed a higher VTE incidence in females and the elderly, which was consistent with estimates from studies in other jurisdictions.
THROMBOSIS RESEARCH
(2021)
Review
Medicine, General & Internal
Ming-Yee Sun, Sonu M. M. Bhaskar
Summary: This study aimed to calculate the pooled prevalence of VTE in chemotherapy-treated cancer patients, finding a prevalence rate of 6% which is higher than the overall crude prevalence rate. Comprehensive cancer care should consider stratified VTE risk assessment based on cancer phenotype.
Review
Medicine, General & Internal
Mudassir Wani, Abdullah Al-Mitwalli, Subhabrata Mukherjee, Ghulam Nabi, Bhaskar K. Somani, Jayasimha Abbaraju, Sanjeev Madaan
Summary: The aim of this study was to investigate the occurrence and risk factors of venous thromboembolism (VTE) in post-radical prostatectomy patients. It was found that the overall incidence of VTE in post-RP patients is 1%, and minimally invasive procedures and RP without pelvic lymph node dissection are associated with a lower risk of developing VTE. Additional pharmacological prophylaxis may not be necessary in all cases and should be considered in high-risk patients only.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Hematology
Rasmus Sogaard Hansen, Mads Nybo, Anne-Mette Hvas
Summary: Pediatric cancer patients with central venous catheters face a significant risk of venous thromboembolism (VTE), especially those with acute lymphoblastic leukemia (ALL). Preferably, implantable port catheters should be used to reduce VTE risk in these patients, along with intensified catheter care.
SEMINARS IN THROMBOSIS AND HEMOSTASIS
(2021)
Review
Oncology
Lin Xiang, Shuai Jin, Yang Yu, Dengfeng Wang, Hao Chen
Summary: This study examined the risk of venous thromboembolism (VTE) after gastric cancer surgery and the clinical value of pharmacological thromboprophylaxis. The results showed that patients undergoing gastric cancer surgery do not have a high risk of VTE, and mechanical plus pharmacological prophylaxis is more effective in preventing postoperative VTE compared to mechanical prophylaxis alone.
Review
Critical Care Medicine
Alexandre Tran, Shannon M. Fernando, Bram Rochwerg, Deborah J. Cook, Mark A. Crowther, Robert A. Fowler, Waleed Alhazzani, Deborah M. Siegal, Lana A. Castellucci, Ryan Zarychanski, Shane W. English, Kwadwo Kyeremanteng, Marc Carrier
Summary: This study aims to identify prognostic factors for the development of venous thromboembolism in the ICU. The results show that factors associated with an increased risk of venous thromboembolism include older age, obesity, active malignancy, history of venous thromboembolism, history of recent surgery, sepsis, lack of pharmacologic prophylaxis, central venous catheter, invasive mechanical ventilation, and use of vasoactive medication.
CRITICAL CARE MEDICINE
(2022)
Review
Medicine, General & Internal
Tom Hillary, Jolien Clijmans, Severine Vermeire, Jo Lambert, Marjan Garmyn, Maya Imbrechts, Thomas Vanassche
Summary: Psoriasis is associated with an increased risk of venous thromboembolism (VTE) but the relationship between the two has been under-researched. Meta-analysis of existing studies showed a significant correlation between psoriasis and VTE, although not statistically significant when compared to healthy controls. Further research is needed to identify subgroups of psoriasis patients at higher risk of developing VTE.
ANNALS OF MEDICINE
(2021)
Review
Medicine, General & Internal
Yunmeng Wang, Chaowei Ding, Chang Guo, Jingru Wang, Suyun Liu
Summary: This study comprehensively investigated the association between thyroid dysfunction and venous thromboembolism (VTE), and found that patients with thyroid dysfunction are at an increased risk of VTE.
Review
Geriatrics & Gerontology
Ting Wu, Zhihong Zuo, Deyi Yang, Xuan Luo, Liping Jiang, Zanxian Xia, Xiaojuan Xiao, Jing Liu, Mao Ye, Meichun Deng
Summary: Venous thromboembolism (VTE) is common in severe COVID-19 patients, with higher incidence in older individuals and male patients. Elevated levels of WBC, D-dimer, APTT, fibrinogen, and CRP were commonly observed in COVID-19 patients with VTE, while lower level of lymphocyte was associated with high risk of developing VTE. Severe condition was more likely to occur in COVID-19 patients who developed VTE, suggesting that thromboembolic events are associated with adverse outcomes in COVID-19 patients.
Review
Pharmacology & Pharmacy
Ruihao Li, Manqiu Yuan, Shixiong Yu, Wenlong Fu, Wu Yu, Siying Ling, Jianming Sun, Yikuan Chen
Summary: The use of statins may reduce the risk of disease recurrence and all-cause mortality in patients with VTE. However, further randomized clinical trials are needed to better explore the effect of statins in secondary prevention of VTE.
PHARMACOLOGICAL RESEARCH
(2021)
Review
Hematology
Lucia Caiano, Marc Carrier, Andrea Marshall, Annie M. Young, Walter Ageno, Aurelien Delluc, Tzu-Fei Wang
Summary: In cancer patients, incidentally detected VTE has lower recurrence rate but a potential increase in major bleeding events compared to symptomatic VTE, with no difference in overall mortality. Risk-benefit ratio of anticoagulation should be considered in patient management.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
(2021)
Review
Environmental Sciences
Haihong Yang, Guan Yang, Meiling Xu, Yuanyuan Zhao, Shengdong He, Qiwu Wang, Yi Wen, Chen Huang, Jianping Wu, Chao Ren, Yongxiang Yang, Siyi He
Summary: This study conducted a meta-analysis and systematic review to investigate the incidence of venous thromboembolism (VTE) at high altitude (HA) compared to low altitude (LA) and identified potential risk factors such as susceptibility genes. The results showed that HA was significantly associated with a higher overall incidence of VTE and that this association persisted at 30/90 days post operation. Analysis of genes in HA-VTE patients revealed several targeted genes.
SCIENCE OF THE TOTAL ENVIRONMENT
(2022)
Review
Oncology
W. -X. Qi, L. -N. Tang, Y. -J. Sun, A. -N. He, F. Lin, Z. Shen, Y. Yao
ANNALS OF ONCOLOGY
(2013)
Article
Oncology
Yu-Jing Huang, Wei-Xiang Qi, Ai-Na He, Yuan-Jue Sun, Zan Shen, Yang Yao
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(2013)
Review
Pharmacology & Pharmacy
Wei-Xiang Qi, Zan Shen, Li-Na Tang, Yang Yao
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
(2014)
Review
Pharmacology & Pharmacy
Wei-Xiang Qi, Zan Shen, Li-Na Tang, Yang Yao
CLINICAL DRUG INVESTIGATION
(2014)
Review
Gastroenterology & Hepatology
W. -X. Qi, Z. Shen, L. -N. Tang, Y. Yao
COLORECTAL DISEASE
(2014)
Review
Oncology
Wei-Xiang Qi, Yuan-Jue Sun, Li-Na Tang, Zan Shen, Yang Yao
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
(2014)
Article
Pharmacology & Pharmacy
Wei-Xiang Qi, Li-Na Tang, Zan Shen, Yang Yao
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
(2014)
Article
Oncology
Wei-Xiang Qi, Shengguang Zhao, Jiayi Chen
Article
Oncology
Wei-Xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen
Article
Oncology
Wei-xiang Qi, Shengguang Zhao, Jiayi Chen
Editorial Material
Oncology
Wei-Xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen
Article
Oncology
Wei Xiang Qi, Lu Cao, Cheng Xu, Jiayi Chen
Summary: The study found that adjuvant radiotherapy significantly improves the survival of patients with primary squamous cell carcinoma of the breast. Further research is needed to investigate the role of adjuvant radiotherapy in PSCC after mastectomy.
JOURNAL OF ONCOLOGY
(2021)
Article
Oncology
Wei-Xiang Qi, Lingyan Chen, Lu Cao, Cheng Xu, Gang Cai, Jiayi Chen
Summary: This study aimed to compare the survival outcomes between HER2-low-positive and HER2-0 breast cancer, regardless of hormone-receptor (HR) status, in Asian women. The results showed no significant survival difference between the two groups, but high Ki-67 index was associated with poorer survival outcomes in HER2-0 breast cancer.
JOURNAL OF ONCOLOGY
(2022)
Article
Oncology
Wei-Xiang Qi, Lu Cao, Siyue Zheng, Cheng Xu, Rong Cai, Haoping Xu, Gang Cai, Jiayi Chen
Summary: The IMNI PRECISION trial aims to determine the optimal adjuvant radiation therapy for early-stage breast cancer patients with positive lymph nodes (T1-2N1). The study randomly assigns patients with high clinical risk but low genomic risk to receive either comprehensive regional nodal irradiation with internal mammary node irradiation or to omit the internal mammary node irradiation. The primary endpoint is event-free survival.
Article
Oncology
Wei-Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao, Hecheng Li
Summary: This study aimed to analyze the relationship between pretreatment inflammatory biomarkers and survival outcomes for patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and pembrolizumab. The results showed that pretreatment absolute lymphocyte count and platelet count were independent predictors for treatment response and prognosis of ESCC.
Article
Oncology
Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa
Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.
INTERNATIONAL JOURNAL OF CANCER
(2024)
Correction
Oncology
J. Gu, S. Xie, S. Wang
INTERNATIONAL JOURNAL OF CANCER
(2024)